A pilot program testing the use of artificial intelligence to expand prior authorization decisions in Medicare has providers, politicians, and researchers questioning Trump administration promises to ...

This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.

Even if people qualify for financial help with their hospital bills, the care they receive may not be covered.

The decisions by the Advisory Committee on Immunization Practices matter, because insurers and federal programs rely on them, but they are not binding. States can follow the recommendations, or not.

Tens of millions of people face sticker shock enrolling in Affordable Care Act insurance for 2026. To save money, the Trump administration wants them to consider less generous coverage.

The White House’s autism announcement exaggerates links to Tylenol, misleads on vaccines, and sets back the field by ignoring decades of research, scientists say.

North Carolina and Idaho are cutting their Medicaid programs to bridge budget gaps, raising fears that providers will stop taking patients and that hospitals will close even before the brunt of a new ...

A federal vaccine panel, recently reshaped by Health and Human Services Secretary Robert F. Kennedy Jr., is expected to vote on delaying the hepatitis B shot for newborns. Pediatricians warn that ...

The U.S. health secretary takes exception to policies he decries as “radical gender ideology.” Some health experts contend Kennedy's decision to reject the declaration is counterintuitive to his MAHA ...

A lack of faith in the soundness of the Centers for Disease Control and Prevention’s new direction has led states to explore enacting their own vaccine policies. A patchwork of divergent ...

As the climate changes, hurricanes are intensifying more quickly, leaving Louisiana’s current mass evacuation plan in limbo. But transportation officials say the price is too high to switch to methods ...